Published in Bioorg Med Chem Lett on January 20, 2010
Wall teichoic acids of gram-positive bacteria. Annu Rev Microbiol (2013) 1.77
Bugs, drugs and chemical genomics. Nat Chem Biol (2011) 1.15
Discovery of wall teichoic acid inhibitors as potential anti-MRSA β-lactam combination agents. Chem Biol (2013) 1.07
An antibiotic that inhibits a late step in wall teichoic acid biosynthesis induces the cell wall stress stimulon in Staphylococcus aureus. Antimicrob Agents Chemother (2012) 0.98
Teichoic acid biosynthesis as an antibiotic target. Curr Opin Microbiol (2013) 0.97
ABC transporters required for export of wall teichoic acids do not discriminate between different main chain polymers. ACS Chem Biol (2011) 0.93
In vitro antimicrobial activity of wall teichoic acid biosynthesis inhibitors against Staphylococcus aureus isolates. Antimicrob Agents Chemother (2010) 0.92
Lipid-linked cell wall precursors regulate membrane association of bacterial actin MreB. Nat Chem Biol (2014) 0.90
Role of wall teichoic acids in Staphylococcus aureus endophthalmitis. Invest Ophthalmol Vis Sci (2011) 0.89
Wall teichoic acid protects Staphylococcus aureus from inhibition by Congo red and other dyes. J Antimicrob Chemother (2012) 0.82
Chemical Genetic Analysis and Functional Characterization of Staphylococcal Wall Teichoic Acid 2-Epimerases Reveals Unconventional Antibiotic Drug Targets. PLoS Pathog (2016) 0.78
Core Steps of Membrane-Bound Peptidoglycan Biosynthesis: Recent Advances, Insight and Opportunities. Antibiotics (Basel) (2015) 0.77
Envelope Structures of Gram-Positive Bacteria. Curr Top Microbiol Immunol (2016) 0.76
Benzopyrimido-pyrrolo-oxazine-dione CFTR inhibitor (R)-BPO-27 for anti-secretory therapy of diarrheas caused by bacterial enterotoxins. FASEB J (2016) 0.75
Accelerating the discovery of antibacterial compounds using pathway-directed whole cell screening. Bioorg Med Chem (2016) 0.75
Multidrug Intrinsic Resistance Factors in Staphylococcus aureus Identified by Profiling Fitness within High-Diversity Transposon Libraries. MBio (2016) 0.75
Staphylococcus aureus resistant to vancomycin--United States, 2002. MMWR Morb Mortal Wkly Rep (2002) 7.34
Role of teichoic acids in Staphylococcus aureus nasal colonization, a major risk factor in nosocomial infections. Nat Med (2004) 5.21
A continuum of anionic charge: structures and functions of D-alanyl-teichoic acids in gram-positive bacteria. Microbiol Mol Biol Rev (2003) 5.18
Epidemiology of methicillin-resistant Staphylococcus aureus. Clin Infect Dis (2008) 4.48
Vancomycin-resistant Staphylococcus aureus--Pennsylvania, 2002. MMWR Morb Mortal Wkly Rep (2002) 3.95
Teichoic acids and related cell-wall glycopolymers in Gram-positive physiology and host interactions. Nat Rev Microbiol (2008) 3.57
Vancomycin-resistant Staphylococcus aureus--New York, 2004. MMWR Morb Mortal Wkly Rep (2004) 3.38
Lesions in teichoic acid biosynthesis in Staphylococcus aureus lead to a lethal gain of function in the otherwise dispensable pathway. J Bacteriol (2006) 2.49
Treatment failure resulting from resistance of Staphylococcus aureus to daptomycin. J Clin Microbiol (2006) 2.12
Discovery of a small molecule that blocks wall teichoic acid biosynthesis in Staphylococcus aureus. ACS Chem Biol (2009) 1.37
Linezolid (ZYVOX), the first member of a completely new class of antibacterial agents for treatment of serious gram-positive infections. J Med Chem (2008) 1.36
Current challenges in treating MRSA: what are the options? Expert Rev Anti Infect Ther (2008) 1.09
Emergence of linezolid resistance in a methicillin resistant Staphylococcus aureus strain. Infection (2007) 1.08
Chemical inhibitor of nonapoptotic cell death with therapeutic potential for ischemic brain injury. Nat Chem Biol (2005) 11.63
Identification of RIP1 kinase as a specific cellular target of necrostatins. Nat Chem Biol (2008) 9.24
The Human Phenotype Ontology project: linking molecular biology and disease through phenotype data. Nucleic Acids Res (2013) 5.66
The bacterial cell envelope. Cold Spring Harb Perspect Biol (2010) 5.14
The SIRT1 deacetylase suppresses intestinal tumorigenesis and colon cancer growth. PLoS One (2008) 4.32
BMP type I receptor inhibition reduces heterotopic [corrected] ossification. Nat Med (2008) 4.20
Lipoprotein cofactors located in the outer membrane activate bacterial cell wall polymerases. Cell (2010) 2.53
Imaging peptidoglycan biosynthesis in Bacillus subtilis with fluorescent antibiotics. Proc Natl Acad Sci U S A (2006) 2.53
Discovery of O-GlcNAc transferase inhibitors. J Am Chem Soc (2005) 2.27
Lipid II is an intrinsic component of the pore induced by nisin in bacterial membranes. J Biol Chem (2003) 2.26
Structure of human O-GlcNAc transferase and its complex with a peptide substrate. Nature (2011) 2.24
Wall teichoic acid function, biosynthesis, and inhibition. Chembiochem (2010) 2.15
Pharmacologic inhibition of the anaphase-promoting complex induces a spindle checkpoint-dependent mitotic arrest in the absence of spindle damage. Cancer Cell (2010) 2.08
Necrostatin-1 reduces histopathology and improves functional outcome after controlled cortical impact in mice. J Cereb Blood Flow Metab (2008) 2.06
Self-reported hepatitis C virus antibody status and risk behavior in young injectors. Public Health Rep (2007) 2.04
Crystal structure of the MurG:UDP-GlcNAc complex reveals common structural principles of a superfamily of glycosyltransferases. Proc Natl Acad Sci U S A (2003) 2.02
Vancomycin analogues active against vanA-resistant strains inhibit bacterial transglycosylase without binding substrate. Proc Natl Acad Sci U S A (2003) 1.96
Necroptosis, a novel form of caspase-independent cell death, contributes to neuronal damage in a retinal ischemia-reperfusion injury model. J Neurosci Res (2010) 1.89
In vitro reconstitution of two essential steps in wall teichoic acid biosynthesis. ACS Chem Biol (2006) 1.89
Cost-effectiveness of point-of-care viral load monitoring of antiretroviral therapy in resource-limited settings: mathematical modelling study. AIDS (2013) 1.88
Discovery of inhibitors that elucidate the role of UCH-L1 activity in the H1299 lung cancer cell line. Chem Biol (2003) 1.85
Wall teichoic acids of gram-positive bacteria. Annu Rev Microbiol (2013) 1.77
Structure-activity relationship study of novel necroptosis inhibitors. Bioorg Med Chem Lett (2005) 1.72
Crystal structure of a peptidoglycan glycosyltransferase suggests a model for processive glycan chain synthesis. Proc Natl Acad Sci U S A (2007) 1.68
Synthetic lethal compound combinations reveal a fundamental connection between wall teichoic acid and peptidoglycan biosyntheses in Staphylococcus aureus. ACS Chem Biol (2010) 1.64
Inhibition of bone morphogenetic protein signaling attenuates anemia associated with inflammation. Blood (2011) 1.61
Remarkable structural similarities between diverse glycosyltransferases. Chem Biol (2002) 1.56
A revised pathway proposed for Staphylococcus aureus wall teichoic acid biosynthesis based on in vitro reconstitution of the intracellular steps. Chem Biol (2008) 1.52
Bacterial transglycosylase inhibitors. Curr Opin Chem Biol (2005) 1.51
Comparative genomics of Canadian epidemic lineages of methicillin-resistant Staphylococcus aureus. J Clin Microbiol (2007) 1.49
A streamlined metabolic pathway for the biosynthesis of moenomycin A. Chem Biol (2007) 1.47
Intrinsic lipid preferences and kinetic mechanism of Escherichia coli MurG. Biochemistry (2002) 1.44
Kinetic characterization of the glycosyltransferase module of Staphylococcus aureus PBP2. J Bacteriol (2005) 1.41
Methicillin resistance in Staphylococcus aureus requires glycosylated wall teichoic acids. Proc Natl Acad Sci U S A (2012) 1.39
Integrative genomic analyses identify BRF2 as a novel lineage-specific oncogene in lung squamous cell carcinoma. PLoS Med (2010) 1.38
Structure-activity relationship study of novel tissue transglutaminase inhibitors. Bioorg Med Chem Lett (2005) 1.38
Discovery of a small molecule that blocks wall teichoic acid biosynthesis in Staphylococcus aureus. ACS Chem Biol (2009) 1.37
Transpeptidase-mediated incorporation of D-amino acids into bacterial peptidoglycan. J Am Chem Soc (2011) 1.37
Analysis of glycan polymers produced by peptidoglycan glycosyltransferases. J Biol Chem (2007) 1.36
A new class of small molecule inhibitor of BMP signaling. PLoS One (2013) 1.36
The structural basis of Cryptosporidium -specific IMP dehydrogenase inhibitor selectivity. J Am Chem Soc (2010) 1.35
Synthesis of heptaprenyl-lipid IV to analyze peptidoglycan glycosyltransferases. J Am Chem Soc (2007) 1.35
Designed inhibitors of insulin-degrading enzyme regulate the catabolism and activity of insulin. PLoS One (2010) 1.35
Methicillin-resistant Staphylococcus aureus colonization or infection in Canada: National Surveillance and Changing Epidemiology, 1995-2007. Infect Control Hosp Epidemiol (2010) 1.35
Triazole inhibitors of Cryptosporidium parvum inosine 5'-monophosphate dehydrogenase. J Med Chem (2009) 1.33
Cutaneous metastases in breast cancer. Clin J Oncol Nurs (2011) 1.30
The direction of glycan chain elongation by peptidoglycan glycosyltransferases. J Am Chem Soc (2007) 1.28
Structure-activity relationship study of tricyclic necroptosis inhibitors. J Med Chem (2007) 1.27
Carboetomidate: a pyrrole analog of etomidate designed not to suppress adrenocortical function. Anesthesiology (2010) 1.27
Ramoplanin inhibits bacterial transglycosylases by binding as a dimer to lipid II. J Am Chem Soc (2003) 1.24
Differential inhibition of Staphylococcus aureus PBP2 by glycopeptide antibiotics. J Am Chem Soc (2005) 1.23
Late-stage polyribitol phosphate wall teichoic acid biosynthesis in Staphylococcus aureus. J Bacteriol (2008) 1.22
Evc2 is a positive modulator of Hedgehog signalling that interacts with Evc at the cilia membrane and is also found in the nucleus. BMC Biol (2011) 1.21
HCF-1 is cleaved in the active site of O-GlcNAc transferase. Science (2013) 1.21
The mechanism of action of ramoplanin and enduracidin. Mol Biosyst (2005) 1.21
Identification of active-site inhibitors of MurG using a generalizable, high-throughput glycosyltransferase screen. J Am Chem Soc (2003) 1.20
Structural snapshots of the reaction coordinate for O-GlcNAc transferase. Nat Chem Biol (2012) 1.20
Structural analysis of the contacts anchoring moenomycin to peptidoglycan glycosyltransferases and implications for antibiotic design. ACS Chem Biol (2008) 1.19
Complete characterization of the seventeen step moenomycin biosynthetic pathway. Biochemistry (2009) 1.19
Forming cross-linked peptidoglycan from synthetic gram-negative Lipid II. J Am Chem Soc (2013) 1.18
Clostridium difficile-associated diarrhea: an emerging threat to pregnant women. Am J Obstet Gynecol (2008) 1.18
Expression and characterization of the isolated glycosyltransferase module of Escherichia coli PBP1b. Biochemistry (2004) 1.17
Moenomycin family antibiotics: chemical synthesis, biosynthesis, and biological activity. Nat Prod Rep (2010) 1.15
Identification of translational activators of glial glutamate transporter EAAT2 through cell-based high-throughput screening: an approach to prevent excitotoxicity. J Biomol Screen (2010) 1.14
Identification of small molecule inhibitors of the mitotic kinase haspin by high-throughput screening using a homogeneous time-resolved fluorescence resonance energy transfer assay. J Biomol Screen (2008) 1.13
In vitro reconstitution of EryCIII activity for the preparation of unnatural macrolides. J Am Chem Soc (2005) 1.13
The role of the substrate lipid in processive glycan polymerization by the peptidoglycan glycosyltransferases. J Am Chem Soc (2010) 1.11
Small molecules that enhance the catalytic efficiency of HLA-DM. J Immunol (2006) 1.10
Lipoprotein activators stimulate Escherichia coli penicillin-binding proteins by different mechanisms. J Am Chem Soc (2013) 1.10
Structure guided design of potent and selective ponatinib-based hybrid inhibitors for RIPK1. Cell Rep (2015) 1.09
Optimization of benzoxazole-based inhibitors of Cryptosporidium parvum inosine 5'-monophosphate dehydrogenase. J Med Chem (2013) 1.09
Isolated peptidoglycan glycosyltransferases from different organisms produce different glycan chain lengths. J Am Chem Soc (2008) 1.09
Discovery of wall teichoic acid inhibitors as potential anti-MRSA β-lactam combination agents. Chem Biol (2013) 1.07
Proton magnetic resonance spectroscopy reveals neuroprotection by oral minocycline in a nonhuman primate model of accelerated NeuroAIDS. PLoS One (2010) 1.07
Small-molecule activator of glutamate transporter EAAT2 translation provides neuroprotection. J Clin Invest (2014) 1.06
Acceptor substrate selectivity and kinetic mechanism of Bacillus subtilis TagA. Biochemistry (2006) 1.06
Coordination of export and glycosylation of landomycins in Streptomyces cyanogenus S136. FEMS Microbiol Lett (2008) 1.05
O-linked N-acetylglucosaminyltransferase inhibition prevents G2/M transition in Xenopus laevis oocytes. J Biol Chem (2007) 1.04
Small-molecule activators of insulin-degrading enzyme discovered through high-throughput compound screening. PLoS One (2009) 1.03
Validation of IMP dehydrogenase inhibitors in a mouse model of cryptosporidiosis. Antimicrob Agents Chemother (2013) 1.03
Small-molecule inducer of β cell proliferation identified by high-throughput screening. J Am Chem Soc (2013) 1.02
Identification of selective inhibitors for the glycosyltransferase MurG via high-throughput screening. Chem Biol (2004) 1.02
Brain creatine elevation and N-Acetylaspartate reduction indicates neuronal dysfunction in the setting of enhanced glial energy metabolism in a macaque model of neuroAIDS. Magn Reson Med (2011) 1.02
A neutral diphosphate mimic crosslinks the active site of human O-GlcNAc transferase. Nat Chem Biol (2011) 1.02
In vivo and in vitro pharmacological studies of methoxycarbonyl-carboetomidate. Anesth Analg (2011) 1.01
Rethinking ramoplanin: the role of substrate binding in inhibition of peptidoglycan biosynthesis. J Am Chem Soc (2002) 1.01
Selective and potent urea inhibitors of cryptosporidium parvum inosine 5'-monophosphate dehydrogenase. J Med Chem (2012) 1.01
Social and Health Factors Associated with Physical Activity among Kuwaiti College Students. J Obes (2011) 1.00
Genetic factors that influence moenomycin production in streptomycetes. J Ind Microbiol Biotechnol (2010) 1.00
Structure-activity relationship study of selective benzimidazole-based inhibitors of Cryptosporidium parvum IMPDH. Bioorg Med Chem Lett (2012) 1.00
Reconstitution of peptidoglycan cross-linking leads to improved fluorescent probes of cell wall synthesis. J Am Chem Soc (2014) 1.00
Small-molecule inhibitors of USP1 target ID1 degradation in leukemic cells. Mol Cancer Ther (2013) 0.99
Kinetic studies of Cdk5/p25 kinase: phosphorylation of tau and complex inhibition by two prototype inhibitors. Biochemistry (2008) 0.99
Development of an ALK2-biased BMP type I receptor kinase inhibitor. ACS Chem Biol (2013) 0.99